abstract |
This invention comprises the compound (1) and the pharmaceutically acceptable salts thereof. Compound (1) is an interleukin-1β converting enzyme inhibitor and is useful for treating inflammatory diseases such as arthritis and inflammatory bowel disease, septic shock, reperfusion injury, shigellosis, and neuroinflammatory disorders such as stroke, multiple sclerosis, and Alzheimer's disease. |